PEGBERON Trademark

Trademark Overview


On Thursday, July 22, 2021, a trademark application was filed for PEGBERON with the United States Patent and Trademark Office. The USPTO has given the PEGBERON trademark a serial number of 90843638. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 4, 2023. This trademark is owned by XIAMEN AMOYTOP BIOTECH CO., LTD.. The PEGBERON trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; Chemical preparations for testing blood for medical purposes; Dietetic substances adapted for medical use; Biocides; first aid kits; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; Clinical medical reagents; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; Medicinal preparations for the mouth ...
pegberon

General Information


Serial Number90843638
Word MarkPEGBERON
Filing DateThursday, July 22, 2021
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedicines for human purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Biological preparations for medical purposes, namely, an immunomodulator with antiviral and anti-tumor effect; Pharmaceutical preparations, namely, an immunomodulator with antiviral and anti-tumor effect; Chemical preparations for testing blood for medical purposes; Dietetic substances adapted for medical use; Biocides; first aid kits; Injectable pharmaceuticals, namely, polyethylene glycol peginterferon alfa-2b injectant for prevention and treatment of infectious diseases and cancer; Clinical medical reagents; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the prevention of infectious diseases, immune system related diseases and cancer; Medicinal preparations for the mouth and as sprays

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameXIAMEN AMOYTOP BIOTECH CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressXiamen, Fujian 361022
CN

Trademark Events


Event DateEvent Description
Tuesday, April 4, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 4, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, April 4, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 12, 2022NON-FINAL ACTION E-MAILED
Monday, December 12, 2022NON-FINAL ACTION WRITTEN
Thursday, May 26, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 26, 2022NON-FINAL ACTION E-MAILED
Thursday, May 26, 2022NON-FINAL ACTION WRITTEN
Saturday, May 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 21, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 21, 2022NON-FINAL ACTION E-MAILED
Thursday, April 21, 2022NON-FINAL ACTION WRITTEN
Friday, April 15, 2022ASSIGNED TO EXAMINER
Thursday, September 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 26, 2021NEW APPLICATION ENTERED